A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI)

INTRODUCTION: Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide despite the latest therapeutic advances designed to decrease myocardial injury. Preclinical and emerging clinical evidence show that the intracoronary injection of autologous bone marrow mononu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamshere, Stephen, Choudhury, Tawfiq, Jones, Daniel A, Locca, Didier, Mills, Peter, Rothman, Martin, Knight, Charles, Parmar, Mahesh, Agrawal, Samir, Martin, John, Mathur, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931996/
https://www.ncbi.nlm.nih.gov/pubmed/24549163
http://dx.doi.org/10.1136/bmjopen-2013-004258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931996/
https://www.ncbi.nlm.nih.gov/pubmed/24549163
http://dx.doi.org/10.1136/bmjopen-2013-004258

Ejemplares similares